Managers / Q1 2026
MIC Capital Management UK LLP
CIK 0001889830 · FLOOR 7, 25 BERKELEY SQUARE, LONDON, X0, W1J 6HN · (44)02039094610
Summary
Mic Capital Management UK LLP reported $352M in U.S.-listed holdings across 18 positions for Q1 2026.
The portfolio is heavily concentrated: HAYW alone accounts for 24.9% of reported value.
Compared with Q4 2025, the fund opened 2 new positions and exited 1.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 83.4% · $294M
- Other · 16.6% · $58M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| INSGINSEEGO CORP | NEW | +767.2K | 767.2K | +$9M | $9M |
| 6RJ0ROCKET LAB CORP | NEW | +35.6K | 35.6K | +$2M | $2M |
| BABAALIBABA GROUP HLDG LTD | SOLD OUT | −150.0K | 0 | −$22M | $0 |
| RVMDREVOLUTION MEDICINES INC | ADDED | +287.2K | 795.7K | +$37M | $77M |
| HAYWHAYWARD HLDGS INC | TRIMMED | −1.75M | 6.57M | −$41M | $88M |
| KLARNA GROUP PLC | HELD | +0 | 2.71M | −$43M | $36M |
| RXRXRECURSION PHARMACEUTICALS IN | HELD | +0 | 9.64M | −$10M | $30M |
| CPNGCOUPANG INC | HELD | +0 | 1.41M | −$7M | $27M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2026
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | HAYWHAYWARD HLDGS INChistory → | COM | 24.95% | $88M | 6.57M |
| 2 | RVMDREVOLUTION MEDICINES INChistory → | COM | 21.95% | $77M | 795.7K |
| 3 | KLARNA GROUP PLC | SHS | 10.08% | $36M | 2.71M |
| 4 | RXRXRECURSION PHARMACEUTICALS INhistory → | CL A | 8.40% | $30M | 9.64M |
| 5 | QSRRESTAURANT BRANDS INTL INChistory → | COM | 8.10% | $29M | 386.2K |
| 6 | CPNGCOUPANG INChistory → | CL A | 7.57% | $27M | 1.41M |
| 7 | METAMETA PLATFORMS INChistory → | CL A | 5.41% | $19M | 33.3K |
| 8 | GRAB HOLDINGS LIMITED | CLASS A ORD | 5.19% | $18M | 5.00M |
| 9 | NMRANEUMORA THERAPEUTICS INC.history → | COM | 2.47% | $9M | 4.46M |
| 10 | INSGINSEEGO CORPhistory → | COM NEW | 2.42% | $9M | 767.2K |
| 11 | MONDAY COM LTD | SHS | 1.29% | $5M | 66.0K |
| 12 | ACHRARCHER AVIATION INChistory → | COM CL A | 1.03% | $4M | 700.0K |
| 13 | 6RJ0ROCKET LAB CORP | COM | 0.65% | $2M | 35.6K |
| 14 | LYELLYELL IMMUNOPHARMA INC | COM NEW | 0.50% | $2M | 87.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $352M | 18 | May 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $441M | 13 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $500M | 13 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $509M | 16 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $491M | 17 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $706M | 18 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $720M | 15 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $460M | 12 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $527M | 19 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $515M | 19 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $439M | 23 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $492M | 22 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $524M | 25 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $507M | 24 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $555M | 24 | Nov 15, 2022 | RESTATEMENT | changes · EDGAR ↗ |
| Q2 2022 | $511M | 24 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $514M | 23 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $523M | 23 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.